Health
Why Moderna Stock Climbed Today – Motley Fool
One analyst sees gains of nearly 40% ahead for the biotech’s shareholders.
What happened
Shares of Moderna (NASDAQ:MRNA) rose 6.8% on Friday, as analysts and investors grew more optimistic about the vaccine maker’s growth prospects.
So what
Piper Sandler analyst Edward Tenthoff repeated his overweight rating on Moderna’s stock and boosted his price forecast from $208 to $234 on Thursday. His new price target represents potential returns to shareholders of roughly 37% from Moderna’s current share price near $170.
Moderna’s stock price is up sharply in recent days. Image…
-
General24 hours agoTens of thousands protest in nationwide action against war in Gaza
-
General23 hours agoAuthorities say charged man used false name to escape from Perth court
-
Noosa News23 hours agoSkybound Gymnastics owner and coach Wei Jun Lee charged with sexual assault of teenager
-
Noosa News21 hours agoChild sex offenders to be known in Queensland public registry